ISSN: 2278-0238

Revista Internacional de Pesquisa e Desenvolvimento em Farmácia e Ciências da Vida

Acesso livre

Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Abstrato

Nanomedicine for the diagnosis, prevention, and treatment of wide-ranging clinical conditions

Thomas J. Webster

Problem Statement: Medical conditions that are fully or partially irremediable, and which have the potential to leave patients permanently debilitated, are prevalent, despite the wide clinical availability of therapeutics, drugs, and diagnostic tools. Major contemporary health and well-being risks are onset by a slew of causative agents, including antibiotic-resistant microorganisms that prompt facilely transmissible infectious diseases; inherited genetic disorders or mutations that maximize the likelihood of certain cancers in affected individuals; and traumatic injuries that result in lifelong localized pain, disfigurement, or surgical intervention. Methodology: Nanotechnological solutions are dependent on the manipulation of elementary constituents to produce particles or features with dimensions on the order of 100 nm or less, from extremity-to-extremity, and which display optimal quantum effects and enhanced surface area to volume ratios. Facile synthesis approaches, including nanoparticle self-assembly, hydrothermal production, and biogenic methods, have been adapted to achieve these nanodimensions in medical systems. Findings: Unique nanoparticle physiochemical properties, pertaining to size, morphology, and electronic responsiveness contribute to biomolecular impairment and ATP depletion in antagonistic cell types. For instance, noble metal and metal oxide nanoparticles have demonstrated anti-bacterial and anti-cancer efficacy following their application within in vitro and in vivo environments. Targeted delivery has been successfully approached through the synthesis of nanocarriers loaded with various drugs, proteins, genetic materials, and fluorescent probes. Nanofibrous or nanofeatured orthopedic scaffolds with optimal surface energies and mechanical properties have aided in implant optimization. Conclusions: Advances in nanotechnology will produce an index of safe and versatile treatments that functionally exceed current regimens, or that warrant clinical solutions to otherwise untreatable medical complications or conditions.